v3.19.3

Stockholders' Deficit (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2019
Series RX-1 Preferred Stock [Member] |
Schedule of preferred stock transactions |
Series RX-1 Preferred Stock Debt Holder |  | Aggregate Principal and Interest Consideration Exchanged/Paid |  | Total Number of Series RX-1 Preferred Shares Issued |  | Total Number of Common Shares Into Which Shares are Convertible (Before Any Potential Adjustment)
Related party investor (also a shareholder) |  | $ | 69,041 |  |  |  | 52,325 |  |  |  | 5,232,500 |
Related party investor (also a shareholder) |  |  | 458,729 |  |  |  | 324,262 |  |  |  | 32,426,200 |
Company’s outside director (also a shareholder) |  |  | 73,560 |  |  |  | 65,396 |  |  |  | 6,539,600 |
Company’s outside director (also a shareholder) |  |  | 36,583 |  |  |  | 32,367 |  |  |  | 3,236,700 |
Company’s outside director (also a shareholder) |  |  | 22,510 |  |  |  | 20,351 |  |  |  | 4,070,200 |
Related party investor (also a shareholder) |  |  | 22,580 |  |  |  | 20,483 |  |  |  | 2,048,300 |
Company’s general counsel (also a shareholder) |  |  | 37,251 |  |  |  | 33,873 |  |  |  | 3,387,300 |
Related party investor (also a shareholder) |  |  | 1,070,974 |  |  |  | 822,639 |  |  |  | 82,263,900 |
Non-related party investor |  |  | 34,952 |  |  |  | 26,568 |  |  |  | 2,656,800 |
Combined Total |  | $ | 1,826,180 |  |  |  | 1,418,615 |  |  |  | 141,861,500 |
Series RX-2 Preferred Stock [Member] |
Schedule of preferred stock transactions |
Series RX-2 Preferred Stock Warrant Debt Holder |  | Aggregate Principal and Interest Consideration Exchanged/Paid |  | Total Number of RX- 2 Shares For Which Warrants Issued Are Exercisable |  | Total Number of Common Shares Into Which Shares are Convertible (Before Any Potential Adjustment)
Related party employee (also a shareholder) |  | $ | 29,003 |  |  |  | 58,006 |  |  |  | 5,800,600 |
Company’s outside director (also a shareholder) |  |  | 149,021 |  |  |  | 298,042 |  |  |  | 29,804,200 |
Company’s outside director (also a shareholder) |  |  | 51,924 |  |  |  | 103,848 |  |  |  | 10,384,800 |
Related party consultant (also a shareholder) |  |  | 87,009 |  |  |  | 174,018 |  |  |  | 17,401,800 |
Related party consultant (also a shareholder) |  |  | 81,651 |  |  |  | 163,302 |  |  |  | 16,330,200 |
Related party consultant (also a shareholder) |  |  | 92,050 |  |  |  | 184,100 |  |  |  | 18,410,000 |
Combined Total |  | $ | 490,658 |  |  |  | 981,316 |  |  |  | 98,131,600 |
Series RX-3 Preferred Stock [Member] |
Schedule of preferred stock transactions |
Series RX-3 Preferred Stock Warrant Debt Holder |  | Aggregate Principal and Interest Consideration Exchanged/Paid |  | Total Number of RX- 3 Shares For Which Warrants Issued Are Exercisable |  | Total Number of Common Shares Into Which Shares are Convertible (Before Any Potential Adjustment)
Company’s controller (also a shareholder) |  | $ | 235,775 |  |  |  | 81,806 |  |  |  | 81,806,000 |
Company’s president and chief executive officer (also a shareholder) |  |  | 609,716 |  |  |  | 211,733 |  |  |  | 211,733,000 |
Company’s general counsel (also a shareholder) |  |  | 552,156 |  |  |  | 187,673 |  |  |  | 187,673,000 |
Combined Total |  | $ | 1,397,647 |  |  |  | 481,212 |  |  |  | 481,212,000 |

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(i)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=find_SeriesRXOnePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=find_SeriesRXTwoPreferredStockWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=find_SeriesRXThreePreferredStockWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |